Trust Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.4K Sell
103
-10
-9% -$161 ﹤0.01% 577
2026
Q2
$2.32K Buy
113
+112
+11,200% +$2.56K ﹤0.01% 536
2026
Q1
$22 Hold
1
– – ﹤0.01% 903
2025
Q4
$12 Buy
+1
New +$13 ﹤0.01% 888
2020
Q4
– Sell
-16
Closed -$1K – 293
2020
Q3
$1K Sell
16
-40
-71% -$772 ﹤0.01% 305
2020
Q2
$1K Hold
56
– – ﹤0.01% 286
2020
Q1
$1K Buy
56
+40
+250% +$577 ﹤0.01% 277
2019
Q4
$1K Hold
16
– – ﹤0.01% 278
2019
Q3
$1K Hold
16
– – ﹤0.01% 308
2019
Q2
$1K Hold
16
– – ﹤0.01% 291
2019
Q1
$1K Hold
16
– – ﹤0.01% 320
2018
Q4
$1K Hold
16
– – ﹤0.01% 306
2018
Q3
$1K Buy
+16
New +$700 ﹤0.01% 329
2016
Q2
– Sell
-16
Closed – – 351
2016
Q1
$0 Sell
16
-10
-38% -$50 ﹤0.01% 346
2015
Q4
$139 Sell
26
-80
-75% -$511 ﹤0.01% 341
2015
Q3
$1K Buy
+106
New +$1.11K ﹤0.01% 360

Other funds holding CC

Trust Company's CC Position: Q3 2026 in Review

Trust Company reduced its Chemours (CC) stake by 8.8% in Q3 2026, selling an estimated $161 and leaving 103 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Trust Company first reported a position in CC in Q3 2015 and has held it in 16 quarters since. The position peaked at $2.32K in Q2 2026. 262 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Trust Company held 103 shares of Chemours worth $1.4K as of Q3 2026.
  • Trust Company sold 10 Chemours shares in Q3 2026, an estimated $161.
  • Chemours made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #577 holding.
  • Trust Company first reported a position in Chemours in Q3 2015 and has held it in 16 quarters since.
  • Trust Company's Chemours position peaked at $2.32K in Q2 2026.
  • 262 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.